PT  - JOURNAL ARTICLE
ED  - Wilke, William S.
AU  - McHutchison, John G.
AU  - Younossi, Zobair
TI  - Treatment strategies for hepatitis C: Making the best of limited options
DP  - 2000 Jul 01
TA  - Cleveland Clinic Journal of Medicine
PG  - 476--480
VI  - 67
IP  - 7
4099  - http://www.ccjm.org/content/67/7/476.short
4100  - http://www.ccjm.org/content/67/7/476.full
SO  - Cleve Clin J Med2000 Jul 01; 67
AB  - Data from two recent major trials suggest that several changes in clinical practice would benefit hepatitis C patients, including viral genotyping to more accurately determine the duration of therapy, and timely RNA measurement to predict treatment response. Although the combination of interferon alfa-2b and ribavirin therapy has proved superior to interferon alone, the success of interferon-based therapies in eradicating hepatitis C is limited, and the quest for new strategies and treatments continues.